... 二、甲氨蝶呤(Methotrexate,MTX) 三、顺铂(Cisplation) 四、阿糖胞嘧啶(Cytosine arabinoside,Ara-c) ...
基于8个网页-相关网页
Conclusions. The response rate of 145 pationts with advanced esophageal cancer was 45.5%, the new-agent group was 58.8%, the cisplation-group was 50.9%.
结论:145例晚期食管癌化疗有效率45.5%,新药的应用及与顺铂的联合将有效率提高至58.8%。
参考来源 - 145例晚期食管癌的化疗疗效和预后因素分析·2,447,543篇论文数据,部分数据来源于NoteExpress
应用推荐